Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.12Price to Sales
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.18 - $ 1.57 52-Week Range
Ticker Information
Ticker
PSTVCompany Name
PLUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPLUS THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PSTV - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 53.8M | 10.12 | $ 5.32M |
| 3/31/2025 | $ 9.49M | 1.82 | $ 5.21M |
| 12/31/2024 | $ 16.15M | 2.77 | $ 5.82M |
| 9/30/2024 | $ 7.43M | 1.3 | $ 5.72M |
| 6/30/2024 | $ 8.37M | 1.52 | $ 5.51M |
| 3/31/2024 | $ 13.23M | 2.18 | $ 6.08M |
| 12/31/2023 | $ 9.32M | 1.9 | $ 4.91M |
| 9/30/2023 | $ 5.52M | 1.47 | $ 3.75M |
| 6/30/2023 | $ 7.2M | 2.79 | $ 2.58M |
| 3/31/2023 | $ 11.26M | 15.42 | $ 730K |
Key Performance Insights, Last 5 Years
- PLUS THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 8.85.
- Over the past 5 years, PLUS THERAPEUTICS INC's average P/S has been 37.99.
- The median P/S for PLUS THERAPEUTICS INC during this period was 2.79
- PLUS THERAPEUTICS INC reached its highest P/S over the past 5 years at 220.93.
- The lowest P/S recorded by PLUS THERAPEUTICS INC in the same timeframe 1.3
PLUS THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for PLUS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 13.19M ] / Revenues [ $ 1.49M ]
(=) P/S [ 8.85 ] PSTV - Price to Sales, Last 5 years
1.3
Minimum
Sep 30, 2024
220.93
Maximum
Sep 30, 2022
37.99
Average
2.79
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |